{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T04:13:31Z","timestamp":1773029611222,"version":"3.50.1"},"reference-count":10,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"vor","delay-in-days":7845,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[1987,11]]},"abstract":"<jats:p>A 16\u2010yr\u2010old girl with severe von Willebrand disease complicated by the development of precipitating alloantibodies to von Willebrand factor (anti\u2010VWF) had a life\u2010threatening anaphylactoid reaction immediately after the infusion of a commercial plasma concentrate of factor VIII\/von Willebrand factor. An early post\u2010infusion activation of the complement system was demonstrated by the appearance of C3 split products and by the drop of serum CH50 activity, occurring in parallel with a post\u2010infusion drop in the anti\u2010VWF antibody levels. Immune complexes remained unchanged in the early post\u2010infusion period and rose to a moderate extent only after 24 h. We conclude that biologically active products of the complement system contributed to the onset of this life\u2010threatening reaction which occurred after concentrate infusion.<\/jats:p>","DOI":"10.1111\/j.1600-0609.1987.tb01458.x","type":"journal-article","created":{"date-parts":[[2010,7,18]],"date-time":"2010-07-18T13:53:31Z","timestamp":1279461211000},"page":"467-470","source":"Crossref","is-referenced-by-count":55,"title":["Life\u2010threatening reaction to factor VIII concentrate in a patient with severe von Willebrand disease and alloantibodies to von Willebrand factor"],"prefix":"10.1111","volume":"39","author":[{"given":"P. M.","family":"Mannucci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Tamaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Narchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Candotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Federici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Altieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Tedesco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"653","article-title":"Some complications of the therapy of classic hemophilia","volume":"103","author":"Ratnoff OD.","year":"1984","journal-title":"J Lab Clin Med"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V57.1.25.25"},{"key":"e_1_2_1_4_2","first-page":"60","article-title":"Familial incidence of precipitating antibodies in von Willebrand's disease: a study of four cases","volume":"94","author":"Ruggeri ZM","year":"1979","journal-title":"J Lab Clin Med"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-1229(80)90202-0"},{"key":"e_1_2_1_6_2","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/BF03029146","article-title":"Selective C3 deficiency due to C3 nephritic factor in an apparently healthy girl","volume":"15","author":"Tedesco F","year":"1985","journal-title":"La Ricerca Clin Lab"},{"key":"e_1_2_1_7_2","volume-title":"Handbook of Experimental Immunology","author":"Lachmann PJ","year":"1978"},{"key":"e_1_2_1_8_2","doi-asserted-by":"crossref","first-page":"304","DOI":"10.4049\/jimmunol.106.2.304","article-title":"C1q: rapid purification method for preparation of monospecific antisera and for biochemical studies","volume":"106","author":"Yonemasu K","year":"1971","journal-title":"J Immunol"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(83)90423-4"},{"key":"e_1_2_1_10_2","first-page":"645","article-title":"The role of activated complement and granulocytes in shock states and myocardial infaction","volume":"98","author":"Jacob HS.","year":"1981","journal-title":"J Lab Clin Med"},{"key":"e_1_2_1_11_2","volume-title":"Clinical aspects of complement mediated diseases","author":"Teisner B","year":"1983"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.1987.tb01458.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.1987.tb01458.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T16:16:13Z","timestamp":1697904973000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.1987.tb01458.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987,11]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1987,11]]}},"alternative-id":["10.1111\/j.1600-0609.1987.tb01458.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.1987.tb01458.x","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[1987,11]]}}}